Log in

Cronos Group Stock Forecast, Price & News

-0.05 (-0.97 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: $5.08
50-Day Range
MA: $5.44
52-Week Range
Now: $5.08
Volume2.24 million shs
Average Volume6.14 million shs
Market Capitalization$1.78 billion
P/E Ratio11.29
Dividend YieldN/A
Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.
Read More
Cronos Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.94 out of 5 stars

Industry, Sector and Symbol

Industry Medicinals & botanicals
Current SymbolNASDAQ:CRON



Sales & Book Value

Annual Sales$25.64 million
Cash Flow$0.71 per share
Book Value$5.01 per share


Net Income$1.17 billion
Net Margins1,729.07%


Market Cap$1.78 billion
Next Earnings Date11/10/2020 (Estimated)
-0.05 (-0.97 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Cronos Group (NASDAQ:CRON) Frequently Asked Questions

How has Cronos Group's stock been impacted by COVID-19?

Cronos Group's stock was trading at $5.41 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CRON shares have decreased by 6.1% and is now trading at $5.08.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Cronos Group?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating, 4 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Cronos Group

When is Cronos Group's next earnings date?

Cronos Group is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Cronos Group

How were Cronos Group's earnings last quarter?

Cronos Group Inc (NASDAQ:CRON) issued its earnings results on Thursday, August, 6th. The company reported ($0.31) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.06) by $0.25. The business had revenue of $9.88 million for the quarter, compared to the consensus estimate of $12.29 million. Cronos Group had a negative return on equity of 2.57% and a net margin of 1,729.07%. The company's revenue was up 29.2% on a year-over-year basis. During the same period last year, the firm earned $0.22 earnings per share.
View Cronos Group's earnings history

What price target have analysts set for CRON?

9 analysts have issued 1 year price objectives for Cronos Group's shares. Their forecasts range from $6.50 to $17.00. On average, they expect Cronos Group's share price to reach $9.83 in the next year. This suggests a possible upside of 93.6% from the stock's current price.
View analysts' price targets for Cronos Group

Are investors shorting Cronos Group?

Cronos Group saw a increase in short interest in August. As of August 14th, there was short interest totaling 51,260,000 shares, an increase of 9.9% from the July 30th total of 46,660,000 shares. Based on an average daily trading volume, of 4,880,000 shares, the days-to-cover ratio is presently 10.5 days. Currently, 29.0% of the company's stock are short sold.
View Cronos Group's Short Interest

Who are some of Cronos Group's key competitors?

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Tilray (TLRY), Aphria (APHA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and OrganiGram (OGI).

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people:
  • Mr. Michael Gorenstein, Chairman, Pres & CEO (Age 31)
  • Mr. David Hsu, Chief Operating Officer
  • Ms. Xiuming Shum, Gen. Counsel & Corp. Sec.
  • Mr. Jeffrey Jacobson, Head of Sales & Bus. Devel.
  • Mr. William Hilson, Chief Commercial Officer

What is Cronos Group's stock symbol?

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

Who are Cronos Group's major shareholders?

Cronos Group's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (1.53%), FMR LLC (0.31%), FMR LLC (0.31%), Swiss National Bank (0.23%), Man Group plc (0.20%) and TD Asset Management Inc. (0.17%).
View institutional ownership trends for Cronos Group

Which major investors are selling Cronos Group stock?

CRON stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Goldman Sachs Group Inc., Gerber Kawasaki Wealth & Investment Management, Advisor Group Holdings Inc., APG Asset Management N.V., Zurcher Kantonalbank Zurich Cantonalbank, Asset Management Corp IL ADV, and State of Wisconsin Investment Board.
View insider buying and selling activity for Cronos Group

Which major investors are buying Cronos Group stock?

CRON stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, FMR LLC, Man Group plc, Virtu Financial LLC, Wedbush Securities Inc., Mn Services Vermogensbeheer B.V., Marshall Wace LLP, and Toronto Dominion Bank.
View insider buying and selling activity for Cronos Group

How do I buy shares of Cronos Group?

Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately $5.08.

How big of a company is Cronos Group?

Cronos Group has a market capitalization of $1.78 billion and generates $25.64 million in revenue each year. The company earns $1.17 billion in net income (profit) each year or $0.67 on an earnings per share basis. Cronos Group employs 291 workers across the globe.

What is Cronos Group's official website?

The official website for Cronos Group is www.thecronosgroup.com.

How can I contact Cronos Group?

Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The company can be reached via phone at 416-504-0004.

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.